Follow

QUANTUM GENOMICS

Euronext Growth Paris (France)

Quantum Genomics is a biotechnology company that specializes in the research and development of drugs for the treatment of cardiovascular diseases such as high blood pressure and heart failure.

Sector:
HEALTH CARE
>
Biotechnology
Pharmaceuticals And Biotechnology
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
ALQGC
FR0011648971
Euronext Growth Paris
France (FR)
Details of share in QUANTUM GENOMICS with ticker ALQGC
Status
Active
Amount of instruments
21 159 751
Currency
EUR
Segment
Euronext Growth public offering
Type
Ticker
ISIN
Market
SHARE
ALQGC
FR0011648971
Euronext Growth Paris
France (FR)
Details of share in QUANTUM GENOMICS with ticker ALQGC
Status
Active
Amount of instruments
21 159 751
Currency
EUR
Segment
Euronext Growth public offering
Type
Ticker
ISIN
Market
OPTION
QGCBT
FR0013274545
Euronext Growth Paris
France (FR)
Details of option in QUANTUM GENOMICS with ticker QGCBT
Status
Archived
Amount of instruments
2 031 506
Currency
EUR
Segment
Euronext Growth public offering
Terms
People
Jean Philippe Milon
CEO
Jean-Philippe Milon
Board member
Benoît Gueugnon
Board member
Fabrice Balavoine
Board member
Benoît Gueugnon
Board member
Company Details
Sector
HEALTH CARE

Address
33 RUE MARBEUF
Zip code
75008
City/district
PARIS 8
Country
France (FR)
Registration number
487996647
LEI code
969500TFCD8K9RPM9K97
First trade date
10 Apr 2014
Registration date
23 Dec 2005
Short name
QUANTUM GENOMICS

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More